-
The targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
Southern Finance and Economics, September 27th - Sanofi announced that Dabitou& reg; Dupilumab injection has been approved by the National Medical Products Administration (NMPA) of China for use in a ... -
Sanofi's targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ... -
The bladder cancer targeting drug erdafitinib of Johnson&Johnson was approved in the EU
On August 23rd, Janssen Cilag International NV, a subsidiary of Johnson&Johnson, announced that the European Commission (EC) has approved BALVERSA& reg; (erdafitinib) is a daily oral monotherapy used ... -
AstraZeneca lung cancer targeted drug Teresa has been approved for new indications in China
AstraZeneca announced on June 26 that the National Medical Products Administration of China officially approved Teresa& on June 18, 2024; reg; The combination of pemetrexed and platinum based chemoth ...